BLTE
Price
$69.79
Change
+$4.07 (+6.19%)
Updated
Aug 4 closing price
Capitalization
2.27B
One day until earnings call
HRMY
Price
$34.30
Change
-$1.25 (-3.52%)
Updated
Aug 5, 10:55 AM (EDT)
Capitalization
2.04B
Earnings call today
Interact to see
Advertisement

BLTE vs HRMY

Header iconBLTE vs HRMY Comparison
Open Charts BLTE vs HRMYBanner chart's image
Belite Bio
Price$69.79
Change+$4.07 (+6.19%)
Volume$20.33K
Capitalization2.27B
Harmony Biosciences Holdings
Price$34.30
Change-$1.25 (-3.52%)
Volume$600
Capitalization2.04B
BLTE vs HRMY Comparison Chart in %
Loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLTE vs. HRMY commentary
Aug 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a Hold and HRMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 05, 2025
Stock price -- (BLTE: $69.79 vs. HRMY: $35.54)
Brand notoriety: BLTE and HRMY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BLTE: 39% vs. HRMY: 108%
Market capitalization -- BLTE: $2.27B vs. HRMY: $2.04B
BLTE [@Biotechnology] is valued at $2.27B. HRMY’s [@Biotechnology] market capitalization is $2.04B. The market cap for tickers in the [@Biotechnology] industry ranges from $213.02B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green whileHRMY’s FA Score has 0 green FA rating(s).

  • BLTE’s FA Score: 0 green, 5 red.
  • HRMY’s FA Score: 0 green, 5 red.
According to our system of comparison, HRMY is a better buy in the long-term than BLTE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 6 TA indicator(s) are bullish while HRMY’s TA Score has 7 bullish TA indicator(s).

  • BLTE’s TA Score: 6 bullish, 5 bearish.
  • HRMY’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, HRMY is a better buy in the short-term than BLTE.

Price Growth

BLTE (@Biotechnology) experienced а +12.47% price change this week, while HRMY (@Biotechnology) price change was -0.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.94%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +10.52%.

Reported Earning Dates

BLTE is expected to report earnings on Nov 18, 2025.

HRMY is expected to report earnings on Nov 04, 2025.

Industries' Descriptions

@Biotechnology (-2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($2.27B) has a higher market cap than HRMY($2.04B). BLTE YTD gains are higher at: 10.602 vs. HRMY (3.284). HRMY has higher annual earnings (EBITDA): 238M vs. BLTE (-43.31M). HRMY has higher revenues than BLTE: HRMY (745M) vs BLTE (0).
BLTEHRMYBLTE / HRMY
Capitalization2.27B2.04B111%
EBITDA-43.31M238M-18%
Gain YTD10.6023.284323%
P/E RatioN/A13.56-
Revenue0745M-
Total CashN/A507M-
Total DebtN/A176M-
TECHNICAL ANALYSIS
Technical Analysis
BLTEHRMY
RSI
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
73%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 14 days ago
75%
Declines
ODDS (%)
Bearish Trend 19 days ago
82%
Bearish Trend 5 days ago
76%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DCSYX63.01N/A
N/A
Davis Balanced Fund Y
NBRAX25.88N/A
N/A
Neuberger Berman M/C Intrinsic Val A
FGIKX68.52N/A
N/A
Fidelity Growth & Income K
KDHIX52.05N/A
N/A
DWS CROCI Equity Dividend Inst
ABCSX16.11N/A
N/A
AB Discovery Value C

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
+6.19%
RAIN - BLTE
48%
Loosely correlated
-1.05%
ACOG - BLTE
24%
Poorly correlated
-4.06%
LENZ - BLTE
24%
Poorly correlated
-2.10%
HRMY - BLTE
23%
Poorly correlated
+3.31%
NAMS - BLTE
22%
Poorly correlated
+1.79%
More

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with SNBIF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then SNBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
+3.31%
SNBIF - HRMY
52%
Loosely correlated
N/A
SAGE - HRMY
38%
Loosely correlated
N/A
CYTK - HRMY
37%
Loosely correlated
-0.30%
ANAB - HRMY
35%
Loosely correlated
-1.86%
BMRN - HRMY
33%
Loosely correlated
+3.73%
More